Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Oct 1, 2026Reported sale · Form 4Adam Crystal, President, R&D · $645.6KOpen the filing ↗
- Oct 1, 2026Reported sale · Form 4Adam Crystal, President, R&D · $15.2KOpen the filing ↗
- Sep 22, 2026Reported sale · Form 4Jessica Newcomb, Principal Accounting Officer · $16.0KOpen the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record39224 flagged findings
Reported transactions (Form 4)80since Feb 1, 2024 · and 13 other holdings
Corporate events (8-K)28since Sep 9, 2020
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Regulatory history
Topics detected in its SEC reports, with the original excerpt.
Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.
- 2026-06-10share offering or dilution eventrecentOpen filing ↗“…a 30-day option to purchase up to an additional 3,000,009 shares of its Common Stock (the “Optional Shares,” and together with the…”
+1 more passage from the same document
- “…has an initial exercise price per share of $0.001, subject to certain adjustments. The Pre-Funded Warrants are exercisable…”
- 2026-06-10share offering or dilution eventrecentOpen filing ↗“…consent of J.P. Morgan Securities LLC and Leerink Partners LLC, (1) offer, pledge, sell, contract to sell, sell any option or…”
+1 more passage from the same document
- “…convertible into or exercisable or exchangeable for our common stock (including, without limitation, common stock or such other…”
- 2026-06-10merger or acquisition eventrecentOpen filing ↗“…FOCAD-deleted preclinical models of multiple histologies. Corporate History and Information Tango Therapeutics, Inc. was…”
+1 more passage from the same document
- “…models of multiple histologies. Corporate History and Information Tango Therapeutics, Inc. was incorporated in Delaware on May…”
- 2026-06-08share offering or dilution eventrecentOpen filing ↗“…consent of J.P. Morgan Securities LLC and Leerink Partners LLC, (1) offer, pledge, sell, contract to sell, sell any option or…”
+1 more passage from the same document
- “…stock or any securities convertible into or exercisable or exchangeable for our common stock (including, without limitation, common…”
- 2026-06-08merger or acquisition eventrecentOpen filing ↗“…FOCAD-deleted preclinical models of multiple histologies. Corporate History and Information Tango Therapeutics, Inc. was…”
+1 more passage from the same document
- “…models of multiple histologies. Corporate History and Information Tango Therapeutics, Inc. was incorporated in Delaware on May…”
Original excerpts from SEC filings, untranslated. Not advice and not a prediction.
The 25 most recent filings (of 392)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Sep 22, 26Form 144 ↗Notice of proposed sale
- Sep 3, 26Form 4 ↗Insider transaction
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · amendment
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · TCG Crossover GP II, LLC · 7.0% · event on Jun 30, 26 · amendment
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Woodline Partners LP · 2.5% · event on Jun 30, 26 · amendment
- Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Farallon Capital Management, L.L.C. · 9.8% · event on Jun 30, 26 · amendment
- Aug 14, 26SCHEDULE 13G ↗Passive stake · THE GOLDMAN SACHS GROUP, INC. · 6.0% · event on Jun 30, 26
- Aug 12, 26SCHEDULE 13G/A ↗Passive stake · Adage Capital Management, L.P. · 3.4% · event on Jun 30, 26 · amendment
- Aug 11, 268-K ↗Current report · Other events
- Aug 11, 26424B5 ↗Securities offering
- Aug 11, 268-K ↗Current report · Results
- Aug 11, 2610-Q ↗Quarterly report
- Aug 7, 268-K/A ↗Current report · A senior executive left or was appointed · amendment
- Aug 6, 268-K ↗Current report · A senior executive left or was appointed
- Aug 5, 26Form 4 ↗Insider transaction
- Aug 3, 26Form 144 ↗Notice of proposed sale
- Jun 23, 26Form 3 ↗Insider transaction
- Jun 23, 268-K ↗Current report · A senior executive left or was appointed
Notice of proposed sale · 3 Form 144 filingsshow all 3hide
- Jun 17, 26Form 144 ↗Notice of proposed sale
- Jun 11, 26Form 144 ↗Notice of proposed sale
- Jun 10, 26Form 144 ↗Notice of proposed sale
392 filings on record, the oldest from Jul 30, 20.
Listing the 25 most recent filings of the 392 on record.
1216
3 senior executive changes2026show all 3hide
- Aug 7, 26A senior executive left or was appointed+2 more in the same filing8-K/A 5.02 ↗
- Aug 6, 26A senior executive left or was appointed8-K 5.02 ↗
- Jun 23, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Jun 10, 26Entered a material agreement+1 more in the same filing8-K 1.01 ↗
5 senior executive changes2026show all 5hide
- May 13, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- May 8, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Apr 15, 26A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Jan 8, 26A senior executive left or was appointed+3 more in the same filing8-K 5.02 ↗
- Jan 5, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Nov 21, 25Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Oct 24, 25Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Aug 25, 25A senior executive left or was appointed8-K 5.02 ↗
- Aug 30, 23A senior executive left or was appointed8-K 5.02 ↗
- Aug 10, 23Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Aug 7, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Feb 28, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Aug 13, 21Completed an acquisition or disposal+8 more in the same filing8-K 2.01 ↗
- Apr 14, 21Entered a material agreement+3 more in the same filing8-K 1.01 ↗
2 older filings not shown
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Davis Aaron I.10.0%Dec 30, 24SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- Third Rock Ventures IV, L.P.4.7%Feb 6, 26SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- Farallon Capital Management, L.L.C.9.8%Jun 30, 26SCHEDULE 13G/A ↗29 co-filers on this document — the figure is the largest single stake, not their sum.
- RTW Investments, LP9.3%Mar 31, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- Dapice Joshua J.7.8%Mar 31, 26SCHEDULE 13G/A ↗28 co-filers on this document — the figure is the largest single stake, not their sum.
- TCG Crossover GP II, LLC7.0%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- FMR LLC6.9%Mar 31, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
show 5 more holdershide
- THE GOLDMAN SACHS GROUP, INC.6.0%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
- Nextech Crossover I GP S.a. r.l.5.1%Mar 31, 26SCHEDULE 13G/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum.
- Raymond Debbane4.0%Mar 31, 26SCHEDULE 13G/A ↗8 co-filers on this document — the figure is the largest single stake, not their sum.
- Adage Capital Management, L.P.3.4%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
- Woodline Partners LP2.5%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
Sale intention announced
On Sep 22, Jessica Newcomb filed notice of intent to sell up to $340K. It is filed under a scheduled plan (10b5-1), arranged in advance.
A notice is not a sale: it may not go ahead, may happen in part, or at a different price.
After the notice, they sold $199K across 3 trades on Sep 22, per their Form 4. That is 54% of the shares announced so far, and the window is still open.
View notice (Form 144) ↗+1 more recent notices · 1 with a later sale
- Oct 1, 26Sell$646KAdam CrystalPresident, R&D↗
- Oct 1, 26Sell$15KAdam CrystalPresident, R&D↗
- Sep 22, 26Sell$16KJessica NewcombPrincipal Accounting Officer↗
- Sep 22, 26Sell$122KJessica NewcombPrincipal Accounting Officer↗
- Sep 22, 26Sell$60KJessica NewcombPrincipal Accounting Officer↗
- Sep 1, 26Sell$604KAdam CrystalPresident, R&D↗
- Aug 3, 26Sell$141KAdam CrystalPresident, R&D↗
- Aug 3, 26Sell$594KAdam CrystalPresident, R&D↗
- Jul 1, 26Sell$576KAdam CrystalPresident, R&D↗
- Jul 1, 26Sell$223KAdam CrystalPresident, R&D↗
- Jun 1, 26Sell$137KAdam CrystalPresident, R&D↗
- Jun 1, 26Sell$481KAdam CrystalPresident, R&D↗
There are 12 more transactions in this stretch.
Stock compensation, tax and giftsshow the 16 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Oct 1, 26Compensation$140KAdam CrystalPresident, R&D↗
- Sep 1, 26Compensation$140KAdam CrystalPresident, R&D↗
- Aug 3, 26Compensation$140KAdam CrystalPresident, R&D↗
- Jul 1, 26Compensation$140KAdam CrystalPresident, R&D↗
- Jun 19, 26Compensationamount n/aRobert Azelby↗
- Jun 5, 26Compensationamount n/aSung Lee↗
- Jun 5, 26Compensationamount n/aMace Rothenberg↗
- Jun 5, 26Compensationamount n/aLesley Ann Calhoun↗
- Jun 5, 26Compensationamount n/aJohn B Ketchum↗
- Jun 1, 26Compensation$140KAdam CrystalPresident, R&D↗
- May 1, 26Compensationamount n/aMatthew GallChief Financial Officer↗
- May 1, 26Compensation$140KAdam CrystalPresident, R&D↗
- Apr 29, 26Compensationamount n/aSung Lee↗
- Apr 15, 26Compensation$200KAdam CrystalPresident, R&D↗
- Apr 1, 26Compensation$140KAdam CrystalPresident, R&D↗
- Mar 25, 26Compensation$62KAdam CrystalPresident, R&D↗
The full record holds 141 transactions and goes back to Mar 1, 23.
Its sector and its market
Tango Therapeutics Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Tango Therapeutics Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Tango Therapeutics Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 392 documents on file, from Jul 30, 2020 to Oct 5, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.